314 related articles for article (PubMed ID: 11021816)
21. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
[TBL] [Abstract][Full Text] [Related]
22. Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma.
Whiteman DC; Zhou XP; Cummings MC; Pavey S; Hayward NK; Eng C
Int J Cancer; 2002 May; 99(1):63-7. PubMed ID: 11948493
[TBL] [Abstract][Full Text] [Related]
23. PTEN mutations in endometrial cancers with 10q LOH: additional evidence for the involvement of multiple tumor suppressors.
Simpkins SB; Peiffer-Schneider S; Mutch DG; Gersell D; Goodfellow PJ
Gynecol Oncol; 1998 Dec; 71(3):391-5. PubMed ID: 9887237
[TBL] [Abstract][Full Text] [Related]
24. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
25. Role of PTEN, a lipid phosphatase upstream effector of protein kinase B, in epithelial thyroid carcinogenesis.
Eng C
Ann N Y Acad Sci; 2002 Jun; 968():213-21. PubMed ID: 12119278
[TBL] [Abstract][Full Text] [Related]
26. Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation.
Marsh DJ; Dahia PL; Coulon V; Zheng Z; Dorion-Bonnet F; Call KM; Little R; Lin AY; Eeles RA; Goldstein AM; Hodgson SV; Richardson AL; Robinson BG; Weber HC; Longy M; Eng C
Genes Chromosomes Cancer; 1998 Jan; 21(1):61-9. PubMed ID: 9443042
[TBL] [Abstract][Full Text] [Related]
27. Identification of PTEN mutations in metastatic melanoma specimens.
Celebi JT; Shendrik I; Silvers DN; Peacocke M
J Med Genet; 2000 Sep; 37(9):653-7. PubMed ID: 10978354
[TBL] [Abstract][Full Text] [Related]
28. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.
Fujiwara Y; Hoon DS; Yamada T; Umeshita K; Gotoh M; Sakon M; Nishisho I; Monden M
Jpn J Cancer Res; 2000 Mar; 91(3):287-92. PubMed ID: 10760687
[TBL] [Abstract][Full Text] [Related]
29. Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors.
Hsieh MC; Lin SF; Shin SJ; Liu TC; Chang JG; Lee JP
Kaohsiung J Med Sci; 2000 Jan; 16(1):9-12. PubMed ID: 10741010
[TBL] [Abstract][Full Text] [Related]
30. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
[TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of the PTEN gene in human uterine sarcomas.
Lancaster JM; Risinger JI; Carney ME; Barrett JC; Berchuck A
Am J Obstet Gynecol; 2001 May; 184(6):1051-3. PubMed ID: 11349153
[TBL] [Abstract][Full Text] [Related]
32. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G
Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569
[TBL] [Abstract][Full Text] [Related]
33. Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma.
Koenig A; Bianco SR; Fosmire S; Wojcieszyn J; Modiano JF
Vet Pathol; 2002 Jul; 39(4):458-72. PubMed ID: 12126149
[TBL] [Abstract][Full Text] [Related]
34. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.
Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman JG; Bose S; Wang SI; Parsons R; Sidransky D
Oncogene; 1998 Jun; 16(24):3215-8. PubMed ID: 9671402
[TBL] [Abstract][Full Text] [Related]
35. Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas.
Gimm O; Chi H; Dahia PL; Perren A; Hinze R; Komminoth P; Dralle H; Reynolds PR; Eng C
J Clin Endocrinol Metab; 2001 Apr; 86(4):1801-5. PubMed ID: 11297621
[TBL] [Abstract][Full Text] [Related]
36. The role of PTEN, a phosphatase gene, in inherited and sporadic nonmedullary thyroid tumors.
Eng C
Recent Prog Horm Res; 1999; 54():441-52; discussion 453. PubMed ID: 10548886
[TBL] [Abstract][Full Text] [Related]
37. Genetic alterations of the tumor suppressor gene PTEN/MMAC1 in human brain metastases.
Hahn M; Wieland I; Koufaki ON; Görgens H; Sobottka SB; Schackert G; Schackert HK
Clin Cancer Res; 1999 Sep; 5(9):2431-7. PubMed ID: 10499615
[TBL] [Abstract][Full Text] [Related]
38. PTEN/MMAC1 expression in melanoma resection specimens.
Deichmann M; Thome M; Benner A; Egner U; Hartschuh W; Näher H
Br J Cancer; 2002 Dec; 87(12):1431-6. PubMed ID: 12454773
[TBL] [Abstract][Full Text] [Related]
39. Analysis of genetic and epigenetic alterations of the PTEN gene in gastric cancer.
Sato K; Tamura G; Tsuchiya T; Endoh Y; Sakata K; Motoyama T; Usuba O; Kimura W; Terashima M; Nishizuka S; Zou T; Meltzer SJ
Virchows Arch; 2002 Feb; 440(2):160-165. PubMed ID: 11964046
[TBL] [Abstract][Full Text] [Related]
40. Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
Tsao H; Goel V; Wu H; Yang G; Haluska FG
J Invest Dermatol; 2004 Feb; 122(2):337-41. PubMed ID: 15009714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]